Christopher P. Tinworth

558 citations
9 papers · 379 indexed · h-index 7
Topics
Protein Degradation and Inhibitors (5 papers)Ubiquitin and proteasome pathways (3 papers)Multiple Myeloma Research and Treatments (3 papers)

In The Last Decade

Christopher P. Tinworth

9 papers receiving 366 citations

Peers

Christopher P. Tinworth
Comparison fields: 5 of 53
  • Molecular Biology 306
  • Oncology 135
  • Hematology 79
  • Organic Chemistry 68
  • Computational Theory and Mathematics 42
Replace Daniel Meibom with:
Daniel Meibom Germany
Elizabeth Ornelas United States
Erick A. Goldman United States
Michael Meyring Germany
Noriyasu Haginoya Japan
Joshua D. Hansen United States
Diego García Jiménez Italy
Victoria G. Klein United States
Erli Zhang United States
Yanle Zhi China
Christopher P. Tinworth relative to Daniel Meibom Germany Daniel Meibom's profile →
Citations per field
00.5×4.7×
Daniel Meibom · 1×
Citations per year

Countries citing papers authored by Christopher P. Tinworth

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Tinworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Tinworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Tinworth more than expected).

Fields of papers citing papers by Christopher P. Tinworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Tinworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Tinworth. The network helps show where Christopher P. Tinworth may publish in the future.

Co-authorship network of co-authors of Christopher P. Tinworth

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Tinworth. A scholar is included among the top collaborators of Christopher P. Tinworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Tinworth. Christopher P. Tinworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 6
2 2
3 35
4 88
5 13
6 67
7 11
8 134
9 23

About Christopher P. Tinworth

Christopher P. Tinworth is a scholar working on Hematology, Pharmacology and Oncology, having authored 9 papers that have together received 379 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (79 citations), Oncology (135 citations) and Molecular Biology (306 citations). Christopher P. Tinworth has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Robert J. Young, John D. Harling, Han Dai, Ian Churcher, Zuni I. Bassi, Ian E. Smith, Marcus Bantscheff, Marcel Muelbaier, William J. Kerr and Glenn A. Burley. Their work appears in journals such as Nature Communications, Chemical Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026